Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft...
WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty...
globenewswire.com